Growth Metrics

Insight Molecular Diagnostics (IMDX) Total Debt (2020 - 2025)

Historic Total Debt for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $1.1 million.

  • Insight Molecular Diagnostics' Total Debt rose 7198.7% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 7198.7%. This contributed to the annual value of $228000.0 for FY2024, which is 9014.69% down from last year.
  • Per Insight Molecular Diagnostics' latest filing, its Total Debt stood at $1.1 million for Q3 2025, which was up 7198.7% from $689000.0 recorded in Q2 2025.
  • Insight Molecular Diagnostics' 5-year Total Debt high stood at $12.3 million for Q2 2021, and its period low was $109000.0 during Q3 2022.
  • Over the past 5 years, Insight Molecular Diagnostics' median Total Debt value was $689000.0 (recorded in 2025), while the average stood at $1.8 million.
  • Per our database at Business Quant, Insight Molecular Diagnostics' Total Debt plummeted by 9548.47% in 2022 and then soared by 202293.58% in 2023.
  • Quarter analysis of 5 years shows Insight Molecular Diagnostics' Total Debt stood at $1.4 million in 2021, then plummeted by 92.15% to $109000.0 in 2022, then surged by 2022.94% to $2.3 million in 2023, then tumbled by 90.15% to $228000.0 in 2024, then soared by 363.16% to $1.1 million in 2025.
  • Its Total Debt stands at $1.1 million for Q3 2025, versus $689000.0 for Q2 2025 and $433000.0 for Q1 2025.